INR 6.0
(-1.98%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -97.2 Million | 376.59 Million | 69.37 Million | -58.18 Million | 351.35 Million | 417.73 Million |
Net Income | -161.2 Million | -17.51 Million | -21.7 Million | -45.08 Million | 10.12 Million | 29.63 Million |
Depreciation & Amortization | 124.6 Million | 138.81 Million | 140.39 Million | 174.88 Million | 228.56 Million | 44.55 Million |
Deferred income taxes | - | - | - | - | 17.78 Million | - |
Stock-based compensation | - | - | - | - | 70 Thousand | - |
Change in working capital | -57.4 Million | 230.21 Million | -34.1 Million | -351.66 Million | 133.57 Million | 374.1 Million |
Other non-cash items | 266.1 Million | 25.08 Million | -15.22 Million | 163.68 Million | -38.75 Million | -30.55 Million |
Investing Cash Flow | -3.8 Million | -172.07 Million | -630 Thousand | -1.56 Million | -385.9 Million | -668.85 Million |
Investments in PPE | -3.7 Million | -5.02 Million | -4.3 Million | -5.98 Million | -387.68 Million | -187.82 Million |
Acquisitions | 10 Thousand | - | 580 Thousand | 40 Thousand | - | 481.03 Million |
Investment purchases | - | -173.44 Million | -120.7 Million | - | - | -482.76 Million |
Sales/Maturities of investments | - | - | 123.8 Million | - | 1.78 Million | 1.73 Million |
Other Investing Activities | -100 Thousand | 6.39 Million | -10 Thousand | 4.38 Million | 1.78 Million | -481.03 Million |
Financing Cash Flow | -3.4 Million | 500 Thousand | -59.1 Million | -6.43 Million | 7.28 Million | 305.26 Million |
Debt repayment | - | - | - | -17.68 Million | - | -1.31 Billion |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | -58.5 Million | - | - | - |
Common Stock Issuance | - | 4.16 Million | -58.5 Million | - | 10 Million | 1.61 Billion |
Other Financing Activities | -3.4 Million | -3.66 Million | 57.9 Million | -6.43 Million | -2.72 Million | -2.8 Million |
Accounts receivables | -23.1 Million | 20.7 Million | 30.24 Million | 78.6 Million | -58.33 Million | 339.97 Million |
Accounts payables | 3 Million | -46.46 Million | -56.53 Million | -229.64 Million | 63.86 Million | - |
Inventory | - | 46.46 Million | 56.53 Million | 20.59 Million | 8.64 Million | 8.14 Million |
Other working capital | -37.3 Million | 209.51 Million | -64.34 Million | -221.21 Million | 119.4 Million | 25.99 Million |
Cash at beginning of period | 247.72 Million | 42.69 Million | 33.04 Million | 58.41 Million | 85.67 Million | 20.8 Million |
Cash at end of period | 146.8 Million | 247.72 Million | 42.69 Million | 33.04 Million | 58.41 Million | 85.67 Million |
Capital Expenditure | -3.7 Million | -5.02 Million | -4.3 Million | -5.98 Million | -387.68 Million | -187.82 Million |
Effect of forex changes on cash | - | 10 Thousand | 10 Thousand | 40.8 Million | 10 Thousand | 31.53 Million |
Net cash flow / Change in cash | -100.92 Million | 205.03 Million | 9.65 Million | -25.37 Million | -27.26 Million | 64.87 Million |
Free Cash Flow | -100.9 Million | 371.57 Million | 65.07 Million | -64.16 Million | -36.33 Million | 229.91 Million |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -39.5 Million | -34.33 Million | -161.2 Million | -49.2 Million | -32.79 Million | -45 Million |
Depreciation & Amortization | - | - | 124.6 Million | 31.07 Million | 31 Million | 32.79 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -57.4 Million | - | - | - |
Other non-cash items | 39.5 Million | 34.33 Million | 266.1 Million | 49.2 Million | 32.79 Million | 45 Million |
Investing Cash Flow | - | - | -3.8 Million | - | - | - |
Investments in PPE | - | - | -3.7 Million | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | -100 Thousand | - | - | - |
Financing Cash Flow | - | - | -3.4 Million | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | -3.4 Million | - | - | - |
Accounts receivables | - | - | -23.1 Million | - | - | - |
Accounts payables | - | - | 3 Million | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | -37.3 Million | - | - | - |
Cash at beginning of period | - | - | 247.72 Million | 191.71 Million | 129.7 Million | 247.72 Million |
Cash at end of period | - | - | 146.8 Million | 253.85 Million | 191.71 Million | 313.31 Million |
Capital Expenditure | - | - | -3.7 Million | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | -100.92 Million | 62.14 Million | 62 Million | 65.59 Million |
Free Cash Flow | - | - | -100.9 Million | 62.14 Million | 62 Million | 65.59 Million |
CLS
JYOTHYLAB
KTYCF
BIOVF
KIRLOSBROS
EVER